{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:38:20Z","timestamp":1794865100756,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128369","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:59:38Z","timestamp":1772099978000},"page":"128369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Workshop report: Improving standardisation of rabies serology methods and procedures"],"prefix":"10.1016","volume":"77","author":[{"given":"Lorraine Marie","family":"McElhinney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Botelho","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Mattiuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine F.R.","family":"Seetahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cliquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128369_bb0005","article-title":"Centers for Disease Control and Prevention. Rabies: CDC Yellow Book 2024","year":"2024","journal-title":"Travel-associated infections & diseases"},{"key":"10.1016\/j.vaccine.2026.128369_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7774\/cevr.2015.4.1.68","article-title":"Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes","volume":"4","author":"Venkataswamy","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2026.128369_bb0015","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.128369_bb0020","article-title":"Rabies vaccine for prophylaxis and treatment of rabies: a narrative review","volume":"16","author":"Kaye","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.vaccine.2026.128369_bb0025","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/cid\/ciad098","article-title":"Fatal human rabies infection with suspected host-mediated failure of post-exposure prophylaxis following a recognized zoonotic exposure-Minnesota, 2021","volume":"77","author":"Holzbauer","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128369_bb0030","article-title":"Centers for Disease Control and Prevention","year":"2025","journal-title":"About rabies"},{"key":"10.1016\/j.vaccine.2026.128369_bb0035","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.128369_bb0040","first-page":"2018","author":"World Health Organization","year":"2018","journal-title":"Rabies vaccines: WHO position paper \u2013 April"},{"key":"10.1016\/j.vaccine.2026.128369_bb0045","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.128369_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(89)90010-8","article-title":"Failure of rabies postexposure treatment in Thailand","volume":"7","author":"Wilde","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128369_bb0055","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1809.111833","article-title":"Inadequate antibody response to rabies vaccine in immunocompromised patient","volume":"18","author":"Kopel","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128369_bb0060","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.vaccine.2019.03.037","article-title":"Avoiding preventable deaths: The scourge of counterfeit rabies vaccines","volume":"37","author":"Taylor","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128369_bb0065","first-page":"ofaa313","article-title":"Counterfeit Rabies Vaccines: The Philippine Experience. Open Forum","volume":"7","author":"Henson","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.128369_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/vaccines7030110","article-title":"The cellular immune response to rabies vaccination: a systematic review","volume":"7","author":"Overduin","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128369_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128369_bb0080","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1016\/j.vaccine.2016.09.058","article-title":"Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans","volume":"34","author":"Mansfield","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128369_bb0085","series-title":"International Conference on Rabies in the Americas Meeting. Quer\u00e9taro, Mexico","article-title":"Immunogenicity of rabies vaccines in postexposure prophylaxis (PEP) or simulated PEP regimens: a systematic literature review and meta-analysis","author":"Morelli","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128369_bb0090","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128369_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2026.128369_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0092-1157(79)80024-4","article-title":"A microtest for the quantitation of rabies virus neutralizing antibodies","volume":"7","author":"Zalan","year":"1979","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2026.128369_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/S0036-46651993000200009","article-title":"Simplified fluorescent inhibition microtest for the titration of rabies neutralizing antibodies","volume":"35","author":"Favoretto","year":"1993","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2026.128369_bb0110","series-title":"Laboratory techniques in rabies","volume":"1","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2026.128369_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2023.114769","article-title":"A simplified method for measuring neutralising antibodies against rabies virus","volume":"319","author":"Wu","year":"2023","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2026.128369_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.06.017","article-title":"Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus","volume":"474","author":"Timiryasova","year":"2019","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2026.128369_bb0125","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1038\/s41598-020-66754-8","article-title":"Preparation and qualification of internal rabies reference standards for use in the rabies rapid fluorescent focus inhibition test","volume":"10","author":"Timiryasova","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128369_bb0130","article-title":"Working Group on Rabies vaccines and immunoglobulins WHOS","author":"SAGE","year":"2017","journal-title":"Background paper: proposed revision of the policy on rabies vaccines and rabies immunoglobulins"},{"key":"10.1016\/j.vaccine.2026.128369_bb0135","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.128369_bb0140","first-page":"1","article-title":"Joint WHO\/IABS symposium on the standardization of rabies vaccines for human use produced in tissue culture [rabies III]","volume":"40","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2026.128369_bb0145","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/v13081516","article-title":"Challenges of rabies serology: defining context of interpretation","volume":"13","author":"Moore","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128369_bb0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.20506\/rst.11.3.622","article-title":"Practical significance of rabies antibodies in cats and dogs","volume":"11","author":"Aubert","year":"1992","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2026.128369_bb0155","doi-asserted-by":"crossref","first-page":"857","DOI":"10.20506\/rst.22.3.1437","article-title":"Neutralising antibody titration in 25,000 sera of dogs and cats vaccinated against rabies in France, in the framework of the new regulations that offer an alternative to quarantine","volume":"22","author":"Cliquet","year":"2003","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2026.128369_bb0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1292\/jvms.13-0335","article-title":"Neutralizing antibody response in dogs and cats inoculated with commercial inactivated rabies vaccines","volume":"76","author":"Shiraishi","year":"2014","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2026.128369_bb0165","series-title":"Laboratory techniques in rabies","volume":"2","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.vaccine.2026.128369_bb0170","author":"World Organisation for Animal Health"},{"key":"10.1016\/j.vaccine.2026.128369_bb0175","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use"},{"key":"10.1016\/j.vaccine.2026.128369_bb0180","first-page":"91","article-title":"Tools for rabies serology to monitor the effectiveness of rabies vaccination in domestic and wild carnivores","volume":"125","author":"Servat","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2026.128369_bb0185","author":"Dianna"},{"key":"10.1016\/j.vaccine.2026.128369_bb0190","author":"World Organisation for Animal Health"},{"key":"10.1016\/j.vaccine.2026.128369_bb0195","series-title":"The relationship between rabies antibody titers in dogs and cats and protection from challenge","author":"Bunn","year":"1984"},{"key":"10.1016\/j.vaccine.2026.128369_bb0200","first-page":"31","article-title":"Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife","volume":"2","author":"Moore","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128369_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.128369_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007824","article-title":"Proficiency test for rabies serology: A design complying with international standards for a reliable assessment of participating laboratories","volume":"13","author":"Wasniewski","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.128369_bb0215","author":"ANSES"},{"key":"10.1016\/j.vaccine.2026.128369_bb0220","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison","volume":"89","author":"Wright","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2026.128369_bb0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v8090254","article-title":"Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles","volume":"8","author":"Moeschler","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.128369_bb0230","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1038\/srep42769","article-title":"Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system","volume":"7","author":"Nie","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128369_bb0235","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/tbed.13826","article-title":"Predicting the presence and titre of rabies virus-neutralizing antibodies from low-volume serum samples in low-containment facilities","volume":"68","author":"Meza","year":"2021","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2026.128369_bb0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2011.10.019","article-title":"Evaluation of ELISA for detection of rabies antibodies in domestic carnivores","volume":"179","author":"Wasniewski","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2026.128369_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207009","article-title":"An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples","volume":"13","author":"Realegeno","year":"2018","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:23:02Z","timestamp":1777537382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"alternative-id":["S0264410X26001775"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128369","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Workshop report: Improving standardisation of rabies serology methods and procedures","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128369"}}